Keith Loria

Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.

Escalating costs are hitting patients hard. CMS price negotiation and the $2,000 cap on Part D out-of-pocket expenses should benefit many patients with Medicare coverage.

From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.

Patients with metabolic syndrome and diabetes may be experiencing challenges outside medication management.

About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2000 monkeypox cases in the United States that occurred during the first 2 months of the outbreak.

ViiV Healthcare reports long-term positive results for its drug, Rukobia (fostemsavir).

Big data and analytics are everywhere—including in independent pharmacy. But is the collected information being used to help with documentation, care planning, and reimbursement?

More of these treatments have been approved, but supply chain issues and cost remain obstacles.

An expert offers considerations and developmentally appropriate interventions to promote high-quality, patient-centered pediatric infusion care.

The risk of breakthrough was higher in people living with HIV regardless of CD4 count or HIV viral suppression, according to findings reported by researchers at Johns Hopkins.

Independent pharmacies can turn this opportunity into a revenue strem